Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes
- 23 August 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 120 (8) , 1658-1667
Abstract
RANTES (CCL5) is a chemokine implicated in many human diseases. We previously showed that the transcription factor Kruppel-like factor 13 (KLF13) controls the late (3-5 days after activation) expression of RANTES in T lymphocytes and that KLF13 itself is translationally regulated through the 5′-untranslated region of its mRNA. Here, we show that KLF13 levels are further regulated by ubiquitination and degradation. KLF13 protein is undetectable in resting human T lymphocytes, but treatment with either proteosomal or lysosomal inhibitors increases KLF13 protein levels. Glycogen synthase kinase 3β (GSK3β)–mediated phosphorylation of KLF13 triggers the ubiquitination of KLF13 by the E3 ligase Fbw7γ, resulting in KLF13 protein degradation. Knockdown of either Fbw7γ or GSK3β by small interfering RNA increases KLF13 expression in resting human T lymphocytes. In contrast, in murine T lymphocytes, KLF13 protein is abundant because of the absence of Fbw7γ. Treatment of unactivated human lymphocytes with lysosomal inhibitors stabilizes KLF13 protein, resulting in an increase of RANTES mRNA and protein. Taken together, these studies found that tightly regulated control of both synthesis and degradation allows rapid changes in the level of KLF13 in human T lymphocytes.Keywords
This publication has 44 references indexed in Scilit:
- KLF13 sustains thymic memory-like CD8+ T cells in BALB/c mice by regulating IL-4–generating invariant natural killer T cellsJournal of Experimental Medicine, 2011
- MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsetsProceedings of the National Academy of Sciences, 2010
- Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligaseJournal of Cell Biology, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Mechanisms of Disease: regulation of RANTES (CCL5) in renal diseaseNature Clinical Practice Nephrology, 2007
- Dynamic Interplay of Transcriptional Machinery and Chromatin Regulates “Late” Expression of the Chemokine RANTES in T LymphocytesMolecular and Cellular Biology, 2007
- Expression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent mannerBiochemical and Biophysical Research Communications, 2006
- EKLF/KLF1 is ubiquitinated in vivo and its stability is regulated by activation domain sequences through the 26S proteasomeFEBS Letters, 2006
- Recognition of Phosphodegron Motifs in Human Cyclin E by the SCFFbw7 Ubiquitin LigaseJournal of Biological Chemistry, 2004
- WWP1-dependent ubiquitination and degradation of the lung Krüppel-like factor, KLF2Biochemical and Biophysical Research Communications, 2004